Accession Number:



First Hungarian Conference on Pharmacotherapy

Descriptive Note:

Corporate Author:


Personal Author(s):

Report Date:


Pagination or Media Count:



The Conference on Pharmacotherapy was organized by the Hungarian Academy of Sciences 26-30 April in Budapest. Eighty foreign experts and numerous Hungarian specialists participated. About half of the foreign participants were from capitalistic countries and the rest from socialist countries. A considerable number of experts represented large pharmaceutical companies, naturally interested in the results of Hungarian pharmacological research. It was in every respect justified to bring together experts of various professions interested in pharmacotherapy - pharmacochemists, pharmacologists, clinical specialists -- in one conference. In recent years such overwhelming numbers of reports have been pubshed on new drugs that it became well-nigh impossible even for the expert to keep track of them. The work of the chemist creating the compound, the pharmacologist conducting experiments on animals to try out the drug, and the clinician using the drug on sick people is so closely related that a meeting of these scientists at a conference table may contribute significantly to the solution of problems. The opening speech was offered by Minister of Health Frigyes Doleschall. Next, the history of pharmacological research in Hungary was outlined by Bela Issekutz, member of the Academy, the nestor of Hungarian pharmacologists as discoverer of several drugs he has actively contributed to this history over the past 50 years. The agenda of the conference reflected the great problems and achievements of pharmacotherapy at present of primary interest. Several lectures dealt with current problems of psychopharmacology, a new branch of science which gives reason for new hope in cases of mental disease heretofore considered incurable. It was good news that both lectures in the field reported the discovery of new Hungarian drugs. Jozsef Borsy1s report was on a mild tranquilizer, Trioxa

Subject Categories:

  • Medicine and Medical Research
  • Pharmacology

Distribution Statement: